解读不确定潜力的克隆性血液形成:对脏疾病的方法,机制和影响
Zhi Yu1,2, Caitlyn Vlasschaert3, Pradeep Natarajan2,4,5
1Clinical and Translational Epidemiology Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Journal of the American Society of Nephrology : JASN
|April 15, 2025
概括
不确定潜力的克隆性血液形成 (CHIP) 与慢性病 (CKD) 和急性损伤 (AKI) 有关. 需要进一步的研究来了解CHIP.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
背景情况:
- 慢性病 (CKD) 影响超过10%的美国成年人,患病率随着年龄的增长而增加.
- 不确定潜力的克隆性血液形成 (CHIP) 是由体质突变驱动的与年龄相关的血液疾病,增加了血液恶性瘤和心血管疾病的风险.
- 新出现的证据将CHIP与脏结果联系起来,包括CKD和AKI,独立于传统的风险因素.
研究的目的:
- 审查目前的观察和假设,将CHIP与病联系起来.
- 强调需要研究CHIP在CKD病原和并发性疾病中的作用.
- 探索抗炎药物治疗CHIP相关脏疾病的潜力.
主要方法:
- 这是一篇综述性文章,综合了现有的流行病学,基于细胞和小鼠的研究.
- 它讨论了提出的假设和观察数据,将CHIP与结局联系起来.
- 它在其分析中考虑了CKD和CHIP的异质性.
主要成果:
- CHIP独立地与患CKD和AKI的风险增加有关.
- 通过CHIP导致脏疾病的确切机制尚未完全阐明.
- 在脏疾病中,CHIP可能是因果因素或衰老和并发症的标志物.
结论:
- 人们越来越认识到CHIP是病发展和进展的重要因素.
- 进一步的研究对于确定CHIP和病之间的因果关系和潜在途径至关重要.
- 针对炎症可能为CHIP相关的脏疾病提供治疗策略.
相关概念视频
Kidney Structure
67.0K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
67.0K
Hematopoiesis
4.9K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
4.9K
Lineage Commitment
2.9K
Commitment is the process whereby stem cells:
2.9K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K


